Total Payments
$174,262
2024 Payments
$9,411
Companies
42
Transactions
417
Medicare Patients
1,490
Medicare Billing
$499,330
Payment Breakdown by Category
Other$146,461 (84.0%)
Travel$12,287 (7.1%)
Food & Beverage$10,022 (5.8%)
Consulting$5,465 (3.1%)
Education$27.22 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $128,061 | 66 | 73.5% |
| Honoraria | $18,400 | 8 | 10.6% |
| Travel and Lodging | $12,287 | 29 | 7.1% |
| Food and Beverage | $10,022 | 306 | 5.8% |
| Consulting Fee | $5,465 | 4 | 3.1% |
| Education | $27.22 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $87,970 | 101 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $62,586 | 57 | $0 (2019) |
| NXSTAGE MEDICAL, INC. | $17,408 | 25 | $0 (2024) |
| La Jolla Pharmaceutical Company | $1,854 | 31 | $0 (2023) |
| Relypsa, Inc. | $565.57 | 22 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $403.78 | 13 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $348.89 | 17 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $293.52 | 15 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $260.63 | 9 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $253.09 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,411 | 15 | Alexion Pharmaceuticals, Inc. ($9,225) |
| 2023 | $30,975 | 67 | Alexion Pharmaceuticals, Inc. ($29,213) |
| 2022 | $16,068 | 50 | Alexion Pharmaceuticals, Inc. ($9,201) |
| 2021 | $10,791 | 52 | Alexion Pharmaceuticals, Inc. ($6,304) |
| 2020 | $11,921 | 37 | NxStage Medical, Inc. ($7,297) |
| 2019 | $21,910 | 54 | Mallinckrodt Enterprises LLC ($18,843) |
| 2018 | $53,049 | 80 | Mallinckrodt LLC ($28,487) |
| 2017 | $20,137 | 62 | Mallinckrodt LLC ($15,256) |
All Payment Transactions
417 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Renal Denervation System | ||||||
| 11/13/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/29/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/01/2024 | NXSTAGE MEDICAL, INC. | NXSTAGE SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Nephrology | ||||||
| 09/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Rare Disease | ||||||
| 08/21/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/26/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,260.00 | General |
| 04/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: VACCINES | ||||||
| 03/19/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,155.00 | General |
| 03/05/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: VACCINES | ||||||
| 02/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: ANTIBIOTIC | ||||||
| 02/08/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,260.00 | General |
| 01/31/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,360.00 | General |
| 01/31/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $90.20 | General |
| 01/02/2024 | W. L. Gore & Associates, Inc. | EXCLUDER Conformable AAA Endoprosthesis with Active Control (Device) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Devices | ||||||
| 12/21/2023 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,890.00 | General |
| 12/15/2023 | EAGLE PHARMACEUTICALS, INC. | BYFAVO (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Anesthesiology | ||||||
| 12/14/2023 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,360.00 | General |
| 11/16/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/06/2023 | W. L. Gore & Associates, Inc. | EXCLUDER Conformable AAA Endoprosthesis with Active Control (Device) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Devices | ||||||
| 10/19/2023 | RECORDATI_RARE_DISEASES_INC. | CYSTADROPS (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: OCULAR METABOLIC AGENT | ||||||
| 10/04/2023 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/03/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: KRYSTEXXA | ||||||
| 09/26/2023 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,360.00 | General |
| 09/25/2023 | W. L. Gore & Associates, Inc. | GORE TAG Conformable Thoracic Endoprosthesis (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Devices | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 324 | 878 | $180,675 | $102,733 |
| 2022 | 5 | 399 | 1,147 | $222,731 | $136,513 |
| 2021 | 7 | 434 | 1,132 | $222,353 | $144,431 |
| 2020 | 7 | 333 | 935 | $176,265 | $115,654 |
Total Patients
1,490
Total Services
4,092
Medicare Billing
$499,330
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 67 | 384 | $108,306 | $60,232 | 55.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 80 | 225 | $24,588 | $18,676 | 76.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 211 | $35,870 | $17,597 | 49.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 34 | $7,831 | $4,368 | 55.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $4,080 | $1,860 | 45.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 81 | 457 | $126,281 | $76,436 | 60.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 112 | 385 | $42,571 | $30,260 | 71.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 220 | $37,400 | $19,711 | 52.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 50 | $10,529 | $7,531 | 71.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 35 | 35 | $5,950 | $2,575 | 43.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 84 | 356 | $100,271 | $61,396 | 61.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 108 | 352 | $37,910 | $28,783 | 75.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 229 | $38,930 | $21,228 | 54.5% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 13 | 78 | $21,925 | $17,216 | 78.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 52 | 57 | $12,259 | $8,542 | 69.7% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 15 | 27 | $5,448 | $4,329 | 79.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 33 | 33 | $5,610 | $2,936 | 52.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 41 | 212 | $58,532 | $38,370 | 65.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 26 | 138 | $33,607 | $26,648 | 79.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 65 | 260 | $27,578 | $22,036 | 79.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 143 | 262 | $44,540 | $19,760 | 44.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 25 | 26 | $5,327 | $4,280 | 80.3% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 17 | 21 | $3,960 | $3,169 | 80.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $2,720 | $1,392 | 51.2% |
About Dr. Christopher Hebert, MD
Dr. Christopher Hebert, MD is a Nephrology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912966045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Hebert, MD has received a total of $174,262 in payments from pharmaceutical and medical device companies, with $9,411 received in 2024. These payments were reported across 417 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($128,061).
As a Medicare-enrolled provider, Hebert has provided services to 1,490 Medicare beneficiaries, totaling 4,092 services with total Medicare billing of $499,330. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Dallas, TX
- Active Since 03/18/2006
- Last Updated 03/29/2012
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1912966045
Products in Payments
- ACTHAR (Biological) $62,791
- SOLIRIS (Drug) $14,409
- ULTOMIRIS (Biological) $12,932
- NXSTAGE SYSTEM ONE (Device) $9,818
- System One (Device) $7,351
- Ultomiris (Drug) $3,286
- GIAPREZA (Drug) $1,675
- Veltassa (Drug) $768.28
- JYNARQUE (Drug) $279.57
- Kerendia (Drug) $253.09
- KRYSTEXXA (Biological) $237.77
- LOKELMA (Drug) $217.17
- Auryxia (Drug) $203.97
- RAYALDEE (Drug) $168.09
- Velphoro (Drug) $144.25
- FARXIGA (Drug) $131.72
- Rayaldee (Drug) $125.43
- ELIQUIS (Drug) $111.07
- Parsabiv (Drug) $104.61
- RENVELA (Drug) $103.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Dallas
Dr. Ankit Mehta, M.d, M.D
Nephrology — Payments: $907,733
Nephrology $907,733
Irfan Agha, M.d, M.D
Nephrology — Payments: $278,709
Nephrology $278,709
Robert Toto, Md, MD
Nephrology — Payments: $199,974
Nephrology $199,974
Russell Silverstein, M.d, M.D
Nephrology — Payments: $190,316
Nephrology $190,316
Dr. Sumit Kumar, M.d, M.D
Nephrology — Payments: $158,458
Nephrology $158,458
Dr. Samir Parikh, M.d, M.D
Nephrology — Payments: $76,733
Nephrology $76,733